204 related articles for article (PubMed ID: 36382954)
1. Enhanced Immune Responses to Mucosa by Functionalized Chitosan-Based Composite Nanoparticles as a Vaccine Adjuvant for Intranasal Delivery.
Lin Y; Sun B; Jin Z; Zhao K
ACS Appl Mater Interfaces; 2022 Nov; 14(47):52691-52701. PubMed ID: 36382954
[TBL] [Abstract][Full Text] [Related]
2. Immune enhancement of N-2-Hydroxypropyl trimethyl ammonium chloride chitosan/carboxymethyl chitosan nanoparticles vaccine.
Gao Y; Gong X; Yu S; Jin Z; Ruan Q; Zhang C; Zhao K
Int J Biol Macromol; 2022 Nov; 220():183-192. PubMed ID: 35981671
[TBL] [Abstract][Full Text] [Related]
3. Intranasal immunization with O-2'-Hydroxypropyl trimethyl ammonium chloride chitosan nanoparticles loaded with Newcastle disease virus DNA vaccine enhances mucosal immune response in chickens.
Zhao K; Sun B; Shi C; Sun Y; Jin Z; Hu G
J Nanobiotechnology; 2021 Aug; 19(1):240. PubMed ID: 34380522
[TBL] [Abstract][Full Text] [Related]
4. Chitosan derivative composite nanoparticles as adjuvants enhance the cellular immune response via activation of the cGAS-STING pathway.
Zhao Z; Peng Y; Shi X; Zhao K
Int J Pharm; 2023 Apr; 636():122847. PubMed ID: 36933583
[TBL] [Abstract][Full Text] [Related]
5. Quaternized chitosan nanoparticles loaded with the combined attenuated live vaccine against Newcastle disease and infectious bronchitis elicit immune response in chicken after intranasal administration.
Zhao K; Li S; Li W; Yu L; Duan X; Han J; Wang X; Jin Z
Drug Deliv; 2017 Nov; 24(1):1574-1586. PubMed ID: 29029568
[TBL] [Abstract][Full Text] [Related]
6. Adjuvanted quaternized chitosan composite aluminum nanoparticles-based vaccine formulation promotes immune responses in chickens.
Liu J; Guo S; Jin Z; Zhao K
Vaccine; 2023 May; 41(18):2982-2989. PubMed ID: 37032226
[TBL] [Abstract][Full Text] [Related]
7. Enhancing Mucosal Immune Response of Newcastle Disease Virus DNA Vaccine Using N-2-Hydroxypropyl Trimethylammonium Chloride Chitosan and N,O-Carboxymethyl Chitosan Nanoparticles as Delivery Carrier.
Zhao K; Han J; Zhang Y; Wei L; Yu S; Wang X; Jin Z; Wang Y
Mol Pharm; 2018 Jan; 15(1):226-237. PubMed ID: 29172532
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Chitosan Derivatives Modified Mesoporous Silica Nanoparticles as Delivery Carrier.
Li Q; Wang W; Hu G; Cui X; Sun D; Jin Z; Zhao K
Molecules; 2021 Apr; 26(9):. PubMed ID: 33923304
[TBL] [Abstract][Full Text] [Related]
9. Biological evaluation of N-2-hydroxypropyl trimethyl ammonium chloride chitosan as a carrier for the delivery of live Newcastle disease vaccine.
Zhao K; Sun Y; Chen G; Rong G; Kang H; Jin Z; Wang X
Carbohydr Polym; 2016 Sep; 149():28-39. PubMed ID: 27261727
[TBL] [Abstract][Full Text] [Related]
10. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S
Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762
[TBL] [Abstract][Full Text] [Related]
11. Amoxicillin encapsulated in the N-2-hydroxypropyl trimethyl ammonium chloride chitosan and N,O-carboxymethyl chitosan nanoparticles: Preparation, characterization, and antibacterial activity.
Zhao Z; Han J; Xu S; Jin Z; Yin TH; Zhao K
Int J Biol Macromol; 2022 Nov; 221():613-622. PubMed ID: 36089095
[TBL] [Abstract][Full Text] [Related]
12. O-2'-hydroxypropyltrimethyl ammonium chloride chitosan nanoparticles for the delivery of live Newcastle disease vaccine.
Dai C; Kang H; Yang W; Sun J; Liu C; Cheng G; Rong G; Wang X; Wang X; Jin Z; Zhao K
Carbohydr Polym; 2015 Oct; 130():280-9. PubMed ID: 26076628
[TBL] [Abstract][Full Text] [Related]
13. Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity.
Bento D; Staats HF; Gonçalves T; Borges O
Eur J Pharm Biopharm; 2015 Jun; 93():149-64. PubMed ID: 25818119
[TBL] [Abstract][Full Text] [Related]
14. Mucoadhesive glycol chitosan nanoparticles for intranasal delivery of hepatitis B vaccine: enhancement of mucosal and systemic immune response.
Pawar D; Jaganathan KS
Drug Deliv; 2016; 23(1):185-94. PubMed ID: 24825494
[TBL] [Abstract][Full Text] [Related]
15. Water-soluble N-2-Hydroxypropyl trimethyl ammonium chloride chitosan enhanced the immunogenicity of inactivated porcine parvovirus vaccine vaccination on sows against porcine parvovirus infection.
Zhou M; Qu W; Sun Y; Liang L; Jin Z; Cui S; Zhao K
Immunol Lett; 2020 Jul; 223():26-32. PubMed ID: 32333964
[TBL] [Abstract][Full Text] [Related]
16. Mannose-anchored quaternized chitosan/thiolated carboxymethyl chitosan composite NPs as mucoadhesive carrier for drug delivery.
Jin Z; Hu G; Zhao K
Carbohydr Polym; 2022 May; 283():119174. PubMed ID: 35153010
[TBL] [Abstract][Full Text] [Related]
17. Curdlan sulfate-
Zhang S; Huang S; Lu L; Song X; Li P; Wang F
Int J Nanomedicine; 2018; 13():2377-2394. PubMed ID: 29713168
[TBL] [Abstract][Full Text] [Related]
18. Immunostimulatory effect of N-2-hydroxypropyltrimethyl ammonium chloride chitosan-sulfate chitosan complex nanoparticles on dendritic cells.
Xu C; Xing R; Liu S; Qin Y; Li K; Yu H; Li P
Carbohydr Polym; 2021 Jan; 251():117098. PubMed ID: 33142636
[TBL] [Abstract][Full Text] [Related]
19. Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity.
Pawar D; Mangal S; Goswami R; Jaganathan KS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):550-9. PubMed ID: 23831265
[TBL] [Abstract][Full Text] [Related]
20.
Zhao K; Gao Y; Hu G; Wang L; Cui S; Jin Z
Vaccines (Basel); 2021 Sep; 9(9):. PubMed ID: 34579264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
